KS

Khushboo Sharma

Chief Regulatory Innovation Officer at Accumulus Synergy

Khushboo Sharma has extensive experience in regulatory affairs and innovation in the biotechnology and pharmaceutical industry. Khushboo served as Chief Regulatory Innovation Officer at Accumulus Synergy starting in September 2022. Prior to that, they held various roles at the Biotechnology Innovation Organization, including Chief of Staff, Senior Vice President, and Vice President of Science and Regulatory Affairs. Khushboo also worked at the FDA, where they served as Deputy Super Office Director, Team Lead, Associate Director for Regulatory Affairs, Senior Regulatory Health Project Manager, and Regulatory Health Project Manager. Before that, they worked as an Associate Scientist at The Janssen Pharmaceutical Companies of Johnson & Johnson. Khushboo started their career at Janssen as an intern in Formulation Development.

Khushboo Sharma obtained a B.S. degree in biotechnology from Penn State University between 2002 and 2005. Later, they pursued an MBA in biotechnology and healthcare industry management from the same university, graduating between 2007 and 2009. Khushboo Sharma also holds additional certifications in Advanced Negotiations from Harvard Kennedy School Executive Education and a Regulatory Affairs Certification (RAC) from the Regulatory Affairs Professional Society. The time of obtaining the certifications is not provided.

Location

Great Falls, United States

Links

Previous companies


Org chart

This person is not in the org chart


Teams


Offices

This person is not in any offices


Accumulus Synergy

Accumulus Synergy is a global, nonprofit industry association that is developing a transformative data exchange platform that aims to enable enhanced collaboration and efficiency between life sciences organizations and global health authorities, while also affording users the ability to extract dynamic, data-driven insights. Sponsored by leading biopharmaceutical companies, Accumulus Synergy was formed in 2020 to create innovative solutions that can reduce regulatory review times and transform global data exchange. The non-profit company is creating a first-of-its-kind cloud-based platform between life sciences organizations and and health authorities worldwide. The single-platform approach aims to improve speed, transparencies and efficiencies in the regulatory process by leveraging advanced technology and tools for data exchange. This will help reduce the cost of innovation and ultimately bring patients safe and effective medicines faster.


Industries

Employees

51-200

Links